|
Attention Investors |
|
|
|
|
|
|
|
|
|
|
|
|
|
Your results on : Equity | News | Corporate-News |
|
|
|
Shilpa Pharma Lifesciences fully redeems its outstanding NCDs |
Share Back |
(19:21, 12 Aug 2025) |
Shilpa Medicare announced that its wholly-owned material subsidiary, Shilpa Pharma Lifesciences, has fully redeemed its outstanding senior, secured, rated, unlisted, and redeemable Non-Convertible Debentures (NCDs) on 11 August 2025.
Accordingly, there are no outstanding NCDs as on date with Shilpa Pharma Lifesciences. |
Top |
|
|
|
|
|
|
|
X |
Filing complaints on SCORES |
Easy & Quick |
|
› |
Register on SCORES Portal |
› |
Mandatory details for filing complaints on SCORES
Name |
PAN |
Address |
Mobile No. |
Email ID |
|
› |
Benefits: |
|
|
|
|